RAS MUTATION
Clinical trials for RAS MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS MUTATION trials appear
Sign up with your email to follow new studies for RAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets common Cancer-Causing gene in first human test
Disease control Recruiting nowThis is an early-stage trial testing a new oral drug called AN9025 in people with advanced solid tumors that have specific RAS gene mutations. The main goals are to find a safe dose, understand how the body processes the drug, and see if it shows any early signs of fighting the c…
Matched conditions: RAS MUTATION
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo targets tough cancers in groundbreaking trial
Disease control Recruiting nowThis study is testing whether a new oral drug called TNG462 is safe and effective when combined with other cancer drugs for people with advanced pancreatic or non-small cell lung cancer. The trial will involve about 183 adults whose cancers have specific genetic changes (MTAP los…
Matched conditions: RAS MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New oral cancer drug enters first human safety testing
Disease control Recruiting nowThis is the first study in humans testing PAS-004, an oral medication designed to target specific genetic mutations found in advanced solid tumors. The main goal is to find a safe dose and understand side effects in 48 adults whose cancers have progressed despite standard treatme…
Matched conditions: RAS MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Blood test guides cancer treatment in major trial
Disease control Recruiting nowThis study compares two different drug combinations for people with advanced colorectal cancer that has spread. Researchers want to see if using a simple blood test to guide treatment decisions helps control cancer growth better. The trial will enroll 280 adults who haven't recei…
Matched conditions: RAS MUTATION
Phase: PHASE3 • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New pill targets 'Undruggable' cancer driver in desperate patients
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called RSC-1255 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how well the drug is tolerated, both alone and combined with another medicati…
Matched conditions: RAS MUTATION
Phase: PHASE1 • Sponsor: RasCal Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists launch major hunt for clues to mysterious genetic disorders
Knowledge-focused Recruiting nowThis study aims to better understand a group of rare genetic conditions called RASopathies, which include Noonan Syndrome and Neurofibromatosis. Researchers will collect blood, tissue, and health information from up to 1,000 participants who have or are suspected of having one of…
Matched conditions: RAS MUTATION
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:26 UTC